119 related articles for article (PubMed ID: 8527690)
1. The acetylcholinesterase oxime reactivator HI-6 in man: pharmacokinetics and tolerability in combination with atropine.
Clement JG; Bailey DG; Madill HD; Tran LT; Spence JD
Biopharm Drug Dispos; 1995 Jul; 16(5):415-25. PubMed ID: 8527690
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatta): effect of atropine, diazepam, and methoxyflurane anesthesia.
Clement JG; Lee MJ; Simons KJ; Briggs CJ
Biopharm Drug Dispos; 1990 Apr; 11(3):227-32. PubMed ID: 2328309
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of HI-6 and atropine in anaesthetized pigs after administration by a new autoinjector.
Nyberg AG; Cassel G; Jeneskog T; Karlsson L; Larsson R; Lundström M; Palmer L; Persson SA
Biopharm Drug Dispos; 1995 Nov; 16(8):635-51. PubMed ID: 8573684
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of atropine in dogs after i.m. injection with newly developed dry/wet combination autoinjectors containing HI 6 or HLö 7.
Thiermann H; Radtke M; Spöhrer U; Klimmek R; Eyer P
Arch Toxicol; 1996; 70(5):293-9. PubMed ID: 8852700
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the oximes HI 6 and HLö 7 in dogs after i.m. injection with newly developed dry/wet autoinjectors.
Spöhrer U; Thiermann H; Klimmek R; Eyer P
Arch Toxicol; 1994; 68(8):480-9. PubMed ID: 7802588
[TBL] [Abstract][Full Text] [Related]
6. Effect of poisoning by soman (pinacolyl methylphosphonofluoridate) on the serum half-life of the cholinesterase reactivator HI-6 in mice.
Clement JG; Simons KJ; Briggs CJ
Biopharm Drug Dispos; 1988; 9(2):177-86. PubMed ID: 3370306
[TBL] [Abstract][Full Text] [Related]
7. Intravenous application of HI-6 salts (dichloride and dimethansulphonate) in pigs: comparison with pharmacokinetics profile after intramuscular administration.
Zdarova Karasova J; Zemek F; Kunes M; Kvetina J; Chladek J; Jun D; Bures J; Tachecí I; Kuca K
Neuro Endocrinol Lett; 2013; 34 Suppl 2():74-8. PubMed ID: 24362096
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and disposition kinetics of HI-6 in Beagle dogs.
Baggot JD; Buckpitt A; Johnson D; Brennan P; Chung H
Biopharm Drug Dispos; 1993 Mar; 14(2):93-105. PubMed ID: 8453028
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of the oxime HI-6 from a mixture with atropine sulphate in dogs.
Jovanović D; Kovacević V; Maksimović M
Pharmacol Toxicol; 1992 Nov; 71(5):340-2. PubMed ID: 1448446
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of promising acetylcholinesterase reactivators K027 and K203 in experimental pigs.
Karasova JZ; Kvetina J; Tacheci I; Radochova V; Musilek K; Kuca K; Bures J
Toxicol Lett; 2017 May; 273():20-25. PubMed ID: 28343895
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys.
Busker RW; Zijlstra JJ; Philippens IH; Groen B; Melchers BP
Toxicology; 1996 Sep; 112(3):183-94. PubMed ID: 8845039
[TBL] [Abstract][Full Text] [Related]
12. HI-6 and 2-PAM in sheep: pharmacokinetics and effects on muscle tissue following intramuscular injection.
Moore DH; Hayward IJ; Tucker FS; Lukey B
Biopharm Drug Dispos; 1991 Apr; 12(3):223-32. PubMed ID: 2059672
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and effects of HI 6 in blood and brain of soman-intoxicated rats: a microdialysis study.
Cassel G; Karlsson L; Waara L; Ang KW; Göransson-Nyberg A
Eur J Pharmacol; 1997 Jul; 332(1):43-52. PubMed ID: 9298924
[TBL] [Abstract][Full Text] [Related]
14. Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics.
Worek F; Koller M; Thiermann H; Wille T
Toxicology; 2016 Mar; 350-352():25-30. PubMed ID: 27153754
[TBL] [Abstract][Full Text] [Related]
15. HI-6 pharmacokinetics in rabbits after intravenous and intramuscular administration.
Lukey BJ; Woodard CL; Clark CR; McCluskey MP
J Pharm Pharmacol; 1992 Aug; 44(8):690-2. PubMed ID: 1359099
[TBL] [Abstract][Full Text] [Related]
16. Trimedoxime and HI-6: kinetic comparison after intravenous administration to mice.
Milic B; Maksimovic M; Nedelijkovic M
Pharmacol Toxicol; 1996 Apr; 78(4):269-72. PubMed ID: 8861786
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of HI-6 DMS in a sustained infusion against percutaneous VX poisoning in the guinea-pig.
Whitmore C; Cook AR; Mann T; Price ME; Emery E; Roughley N; Flint D; Stubbs S; Armstrong SJ; Rice H; Tattersall JEH
Toxicol Lett; 2018 Sep; 293():207-215. PubMed ID: 29129798
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a combination of acetylcholinesterase reactivators, HI-6 and obidoxime, against tabun and soman poisoning of mice.
Clement JG; Shiloff JD; Gennings C
Arch Toxicol; 1987; 61(1):70-5. PubMed ID: 3326546
[TBL] [Abstract][Full Text] [Related]
19. Effect of atropine and bispyridinium oximes on respiratory and circulatory function in guinea-pigs poisoned by sarin.
Worek F; Kirchner T; Szinicz L
Toxicology; 1995 Jan; 95(1-3):123-33. PubMed ID: 7825179
[TBL] [Abstract][Full Text] [Related]
20. HI-6 oxime (an acetylcholinesterase reactivator): blood plasma pharmacokinetics and organ distribution in experimental pigs.
Kuneš M; Květina J; Bureš J; Karasová JZ; Pavlík M; Tachecí I; Musílek K; Kuca K
Neuro Endocrinol Lett; 2014; 35 Suppl 2():191-6. PubMed ID: 25638385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
